Schrödinger, Inc. (Nasdaq: SDGR) today announced the grant of inducement equity awards to the company’s newly appointed EVP, ...

Recursion Pharmaceuticals and Schrodinger leverage their respective AI drug discovery platforms to potentially develop distinguished therapeutic candidates.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Cybersecurity stocks were in focus on Thursday as investment firm BTIG said recent channels checks into the space were ...

Here are the latest rating upgrades by Seeking Alpha analysts: Zscaler (NASDAQ:ZS). Hold to buy by Jack Elias. "Despite ...

Detailed price information for Schrodinger Inc (SDGR-Q) from The Globe and Mail including charting and trades.

Schrodinger delivers strong Q1 results, driven by software growth and evolving FDA regulations. Read more to see why SDGR ...

Investing.com -- Schrodinger Inc (NASDAQ: SDGR) said on Tuesday that Richie Jain has been appointed as the new Chief Financial Officer (CFO), succeeding Geoffrey Porges who is set to leave the ...

Schrödinger (NASDAQ:SDGR) said its CFO, Geoffrey Porges, will step down from his role to pursue other opportunities. The firm added that Richie Jain, who previously served as the firm's senior vice ...

Detailed price information for Schrodinger Inc (SDGR-Q) from The Globe and Mail including charting and trades.

(Nasdaq: SDGR) today announced that initial Phase 1 clinical data for SGR-1505, its investigational MALT1 inhibitor, will be presented at the European Hematology Association Annual Congress, taking ...

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The ...